Abstract
No AccessJournal of UrologyUrological Survey: Abstracts: Sexual Function and Dysfunction1 May 1998Local Interferon-Alpha2b is Not an Effective Treatment in Early-Stage Peyronie's Disease H.E.H. Wegner, R. Andresen, H.H. Knispel, and K. Miller H.E.H. WegnerH.E.H. Wegner More articles by this author , R. AndresenR. Andresen More articles by this author , H.H. KnispelH.H. Knispel More articles by this author , and K. MillerK. Miller More articles by this author View All Author Informationhttps://doi.org/10.1097/00005392-199805000-00132AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Local Interferon-Alpha2b is Not an Effective Treatment in Early-Stage Peyronie's Disease." The Journal of Urology, 159(5), pp. 1777–1778 References 1 : Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J. Urol.1997; 158: 1391. Link, Google Scholar 2 : Treatment of Peyronie's disease with intralesional verapamil injection. J. Urol.1997; 158: 1395. Link, Google Scholar Departments of Urology and Radiology, Benjamin Franklin Medical Center, Free University School of Medicine, Berlin, Germany.© 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 159Issue 5May 1998Page: 1777-1778 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information H.E.H. Wegner More articles by this author R. Andresen More articles by this author H.H. Knispel More articles by this author K. Miller More articles by this author Expand All Advertisement PDF downloadLoading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
